A recent article in Neurology discussed the ethical issues surrounding "neuro-enhancement," offering treatments to healthy people in order to improve brain performance. For example, some parents pressure doctors to prescribe ADHD treatments for their kids in order to improve their test-taking ability.
Make prescribing decisions with our comparative charts and treatment algorithms.
Download or print easy-to-read disease leaflets for your patients.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
Biogen Idec has submitted a BLA for Plegridy, a pegylated subcutaneous injectable molecular entity for relapsing forms of multiple sclerosis.
Shipments of Horizant ER tablets have commenced, and are expected to be available to patients in the first week of June.
In middle-aged women, depression is associated with a significantly increased risk of stroke, even after adjustment for lifestyle and physiological variables.
Military personnel with multiple traumatic brain injuries may be at increased risk for suicide.
Social media, email, and other communication technologies have created great opportunities for clinicians to communicate with patients. But being social must be balanced with medical professionalism. MPR investigates.
Despite the commonness and destructive sequelae of stress, Americans are not receiving adequate stress management guidance from their health care providers, according to a recent study.
As Yoda might say, "Wisely, you must choose." The American Academy of Neurology agrees. As part of an industry effort to reduce wasteful practices that contribute to healthcare costs, the AAN published its recommendations, code-named "Choose Wisely."
Many people expect increasing memory loss as they age, but this memory loss can be reduced or stalled with some simple memorization techniques, physical exercise, and a reduction of stress. Here are 75 tips that can help you go from amnesic to elephantic within a few short weeks.
The advent of oral therapy now gives multiple sclerosis patients more options besides injections, which were the mainstay treatment. Currently only three oral treatments have been approved: Aubagio, Gilenya, and Tecfidera. We look at each in detail.